Article
The FDA has approved what is said to be the first soft artificial cornea (AlphaCor, Argus Biomedical Pty. Ltd., Perth, Western Australia) for sale in the United States.
New study highlights retinopathy risk from hair dye use
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Study finds increased air pollution leads to surge in daily eye clinic visits
Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD
Study highlights current and potential roles of AI in glaucoma diagnosis
Study: CRVO patients face higher heart attack risk